Marksans Pharma Limited — Others, 10-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Marksans Pharma Ltd. has announced a board meeting on April 10, 2025, where it will discuss various regulatory matters. The company provided a certificate confirming compliance with SEBI regulations regarding securities dematerialization for the quarter ended March 31, 2025. This compliance demonstrates Marksans' commitment to operational transparency and efficiency, which may bolster investor confidence in its governance practices. The update signals a positive outlook for shareholders, indicating the company's proactive approach to enhancing its operational framework and regulatory adherence.